Funding news for global health researchers January 10, 2022

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Top NIH Funding News

NIH funding news that may be relevant to global health researchers:

• Publication of the Revised NIH Grants Policy Statement (Rev. December 2021) for Fiscal Year 2022 (NOT-OD-22-050), Jan. 4, 2022

Upcoming Deadlines for Fogarty Funding Opportunities

• International Research Scientist Development Award (IRSDA)
  Application deadline: March 9, 2022
  
• Chronic, Noncommunicable Diseases and Disorders Research Training
  Application deadline: July 13, 2022
• Upcoming deadlines for all Fogarty funding opportunities

Funding Opportunities

NIH funding opportunities on which Fogarty is a funding partner:

• U.S. and Low- and Middle-Income Country (LMIC) HIV-associated malignancy research centers (U54 Clinical Trial Optional) (RFA-CA-22-011)
  Application Receipt Date(s): March 30, 2022

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations, and/or foreign components may apply:

• Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) Clinical Centers (U01 Clinical Trial Required) (RFA-DK-21-020)
  Application Receipt Date: March 31, 2022
• Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) (RFA-MH-22-170)
  Application Receipt Date: May 10, 2022
• Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) (RFA-MH-22-171)
  Application Receipt Date: May 10, 2022
• Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) (RFA-CA-22-005)
  Application Receipt Date: September 22, 2022
• HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)(RFA-NS-22-034)
  Application Receipt Date(s): Multiple dates, see announcement.

Other Funding News

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers:

• BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech (NOT-NS-22-052)
  Expiration Date:  June 21, 2024
• Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors (NOT-CA-22-029)
  Expiration Date:  October 9, 2024
• Selective Cell and Network Vulnerability in Aging and Alzheimer’s Disease (NOT-AG-21-040)
  Expiration Date:  November 13, 2024
• Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer's Disease (NOT-AG-21-041)
  Expiration Date:  November 13, 2024
• Deciphering the Glycosylation Code of Alzheimer's Disease (NOT-AG-21-042)
  Expiration Date:  November 13, 2024
• Sensory and Motor System Changes as Predictors of Preclinical Alzheimer’s Disease. (NOT-AG-21-044)
  Expiration Date:  November 13, 2024
• Opportunities for Research in Epidemiology of Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) and Cognitive Resilience (NOT-AG-21-045)
  Expiration Date:  November 13, 2024
• Dementia Care Research: Programs and services for persons with dementia (NOT-AG-21-046)
  Expiration Date:  November 13, 2024
• Sex and Gender Differences in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (AD/ADRD) (NOT-AG-21-050)
  Expiration Date:  November 13, 2024
• Human Cell Biology of Alzheimer's Disease Genetic Variants (NOT-AG-21-052)
  Expiration Date:  November 13, 2024
• Role of Age-Associated Metabolic Changes in Alzheimer's Disease (NOT-AG-21-053)
  Expiration Date:  November 13, 2024

Notice of changes to funding opportunities that may be of interest to global health researchers:

• Notice of Change to Key Dates for NIDA PAR-21-183, " Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)" (NOT-DA-22-001)
  Expiration Date: December 7, 2023

Notices of intent to publish NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations, and/or foreign components may apply:

• Notice of NIMH Intent to Issue Funding Opportunity Announcements and Notice of Special Interest for COVID-19 and Mental Health Research (NOT-MH-22-105)

Non-NIH funding opportunities that may be of interest to global health researchers:

• Call for proposals on infectious diseases (including antimicrobial resistance) and cancer research   from e-ASIA Joint Research Program (the e-ASIA JRP). 
  Application deadline: March 30, 2022